Prospective randomised controlled trial comparing 1% and 2% lignocaine as a form of anaesthesia prior to prostate biopsy
| ISRCTN | ISRCTN43667535 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN43667535 |
| Protocol serial number | N0059132320 |
| Sponsor | Department of Health |
| Funder | Sheffield Teaching Hospitals NHS Foundation Trust (UK) |
- Submission date
- 30/09/2004
- Registration date
- 30/09/2004
- Last edited
- 12/02/2018
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year
Plain English summary of protocol
Not provided at time of registration
Contact information
Mr Santbir Mehta
Scientific
Scientific
University of Sheffield
Urology
Royal Hallamshire Hospital
Sheffield
S26 4SY
United Kingdom
| Phone | +44 (0)788 956 9670/271 2154 |
|---|---|
| sampimehta@aol.com |
Study information
| Primary study design | Interventional |
|---|---|
| Study design | Randomised controlled trial |
| Secondary study design | Randomised controlled trial |
| Study type | Participant information sheet |
| Scientific title | Prospective randomised controlled trial comparing 1% and 2% lignocaine as a form of anaesthesia prior to prostate biopsy |
| Study objectives | To identify any difference in relief of discomfort of prostate biopsy when using 1% or 2% lignocaine periprostatic nerve block |
| Ethics approval(s) | Not provided at time of registration |
| Health condition(s) or problem(s) studied | Prostate cancer |
| Intervention | Prospective randomised controlled trial comparing 1% and 2% lignocaine as a form of anaesthesia prior to prostate biopsy |
| Intervention type | Drug |
| Phase | Not Applicable |
| Drug / device / biological / vaccine name(s) | Lignocaine |
| Primary outcome measure(s) |
Difference on visual analogue scale (VAS) |
| Key secondary outcome measure(s) |
Not provided at time of registration |
| Completion date | 30/04/2004 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Adult |
| Sex | Male |
| Key inclusion criteria | CaP (prostate cancer) patients |
| Key exclusion criteria | Does not match inclusion criteria |
| Date of first enrolment | 01/01/2004 |
| Date of final enrolment | 30/04/2004 |
Locations
Countries of recruitment
- United Kingdom
- England
Study participating centre
University of Sheffield
Sheffield
S26 4SY
United Kingdom
S26 4SY
United Kingdom
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|---|
| IPD sharing plan summary | Not provided at time of registration |
| IPD sharing plan |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Participant information sheet | Participant information sheet | 11/11/2025 | 11/11/2025 | No | Yes |
Editorial Notes
12/02/2018: No publications found, verifying study status with principal investigator.
